logo

For the Inventor, By the Inventor

Concord, MA, United States of America

Nicolai Wagtmann

This inventor holds 13 USPTO granted patents and 20 published patent applications and 2 EPO patents. Top assignees: Innate Pharma, Dragonfly Therapeutics, Inc.. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicolai Wagtmann. Retrieved from https://idiyas.com/inventor/nicolai-wagtmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 92.3

 

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 45(Granted Patents)


Location History:

  • Cassis, FR (2019 - 2020)
  • Concord, MA (US) (2020 - 2023)

Company Filing History:

goldMedal9 out of 68 
 
Innate Pharma
 patents
silverMedal4 out of 14 
 
Dragonfly Therapeutics, Inc.
 patents

Years Active: 2019-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 12384851 - Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of use (2025-08-12),
2. 12384847 - Cancer therapy involving an anti-PD1 antibody and a multi-specific binding protein that binds NKG2D, CD16, and a tumor-associated antigen (2025-08-12),
3. 12275791 - Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of use (2025-04-14),
4. 11787864 - Heterodimeric Fc-fused proteins (2023-10-17),
5. 11623954 - Siglec-9-neutralizing antibodies (2023-04-11),
6. 11572410 - Neutralization of inhibitory pathways in lymphocytes (2023-02-07),
7. 11447545 - Combination therapy using antibody to human Siglec-9 and antibody to human NKG2A for treating cancer (2022-09-20),
8. 11225519 - Treatment of cancers using anti-NKG2A agents (2022-01-18),
9. 11083785 - Siglec-10 antibodies (2021-08-10),
10. 11078274 - Siglec neutralizing antibodies (2021-08-03),
11. 10870700 - Neutralization of inhibitory pathways in lymphocytes (2020-12-22),
12. 10711063 - Neutralization of inhibitory pathways in lymphocytes (2020-07-14),
13. 10329348 - Treatment of cancers using anti-NKG2A agents (2019-06-25),

Title: Nicolai Wagtmann - Innovative Inventor from Concord

Introduction: Nicolai Wagtmann is a renowned inventor based in Concord, MA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Nicolai Wagtmann holds several patents in various technological domains, including artificial intelligence, renewable energy, and biotechnology.

Career Highlights: With a career spanning over two decades, Nicolai Wagtmann has worked with leading tech companies to develop cutting-edge solutions that have revolutionized industries worldwide.

Collaborations: Throughout his career, Nicolai Wagtmann has collaborated with top researchers, engineers, and scientists to bring his innovative ideas to life, resulting in successful products and technologies.

Conclusion: Nicolai Wagtmann's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs in the ever-evolving tech landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…